Card image cap

Tammy Baldwin's Public Statements on Issue: Drugs

Office:

On The Ballot: Running, Democratic for U.S. Senate (WI) - Jr

Current Issue:

Drugs

Current Speech Type:

Letter

All Debate Executive Order Floor Speech Hearing Interview Issue Position Letter News Article Op-Ed Other Pledge Press Conference Press Release Social Media Speech Statement

Date Range

Keyword Search
Reset Search
Page 1 of 3
Date Title
05/20/2022 Letter to Robert M. Califf, MD, Commissioner of the US Food and Drug Administration - Senator Baldwin, Democratic Colleagues To FDA Commissioner: Remove All Unauthorized E-Cigarettes From Market Immediately
04/11/2022 Letter to Various Pharmaceutical CEOs - Baldwin, Maloney, Hassan, King, Fitzpatrick, Lead Bipartisan, Bicameral Group in Calling on Drug Manufacturers to Make Naloxone Available Over the Counter
03/10/2022 Letter to Robert Califf, Commissioner of the U.S. Food and Drug Administration - Romney, Durbin Lead Colleagues in Urging FDA to Regulate E-Cigarettes after Six Month Delay
03/01/2022 Letter to Stephen J. Ubl, President and CEO of PhRMA - Senator Baldwin, Colleagues Call Out Drug Manufacturers For Squeezing American Families With Rapid and Widespread Price Hikes on Prescription Drugs
02/16/2022 Letter to Merrick Garland, Attorney General Dept. of Justice - SENATORS URGE DOJ TO INVESTIGATE SACKLER FAMILY MEMBERS FOR ROLE IN FUELING OPIOID EPIDEMIC
10/06/2021 Letter to the Hon. Rachel L. Levine, M.D., Assistant Secretary of Health and the Hon. Miriam Delphin-Rittmon, Ph.D, Assistant Secretary for Mental Health and Substance Use - Baldwin Urges HHS to Address Unmet Mental Health Needs of Transgender Youth
07/26/2021 Letter to Hon. Robert Drain, New York District Judge - Senator Hassan, Colleagues Oppose Purdue Pharma's Request for Bonuses to Top Executives & Employees Amid Ongoing Opioid Epidemic
02/18/2021 Letter to Joe Biden, President of the United States - Baldwin, Shaheen Lead Colleagues in Calling for Increased Opioid and Substance Use Disorder Funding in President Biden's Budget Proposal
02/18/2021 Letter to Joe Biden, President of the United States - Luján Joins Colleagues in Calling for Increased Opioid and Substance Use Disorder Funding in President Biden's Budget Proposal
02/04/2021 Letter to Dr. Nora D. Volkow, Director of The National Institute on Drug Abuse - Brown, Capito Lead Letter Supporting Enhanced Research and Development of Methamphetamine Treatment Options
11/10/2020 Letter to the Hon. William Barr, Attorney General for the Dept. of Justice - Durbin, Senators Call On DOJ To Stop Plans To Make Purdue Pharma A Public Benefit Corporation
05/22/2020 Letter to Scott Gast, Deputy Counsel to the President - Menendez, Warren, Colleagues Request Newly Appointed "Therapeutics Czar" to Divest from Financial Interest, Resign to Boards of any Pharmaceutical, Medical and Biotech Companies
05/19/2020 Letter to the Hon. Nancy Pelosi, Speaker of the House of Representatives, the Hon. Kevin McCarthy, House Minority Leader, the Hon. Mitch McConnell, Senate Majority Leader, the Hon. Charles Schumer, Senate Minority Leader - U.S. Senators Jeanne Shaheen and Tammy Baldwin Lead Colleagues in Calling for Increased Funding to Treat and Prevent Substance Use Disorders in Coronavirus Relief Package
04/16/2020 Letter to the Hon. Mitch McConnell, Senate Majority Leader, the Hon. Charles Schumer, Senate Minority Leader, the Hon. Richard Shelby, Chairman of the Senate Appropriations Committee, and the Hon. Patrick Leahy, Vice Chairman of the Senate Appropriations Committee - Senators Shaheen & Hassan Call for Increased Investments to Address Mental Health Needs, Including Substance Use Disorder, Resulting from COVID-19 Pandemic
01/31/2020 Letter to Robert Wilkie, Secretary of the Department of Veteran Affairs - Senator Tammy Baldwin Calls on VA Secretary Wilkie to Release state Reports on Prescription Drug Monitoring Compliance
12/17/2019 Letter to the Board of Directors at Perdue Pharma Inc. - Senators Call on Perdue Pharma to Cancel $1.3 Million Bonus for CEO
10/23/2019 Letter to the Hon. Mitch McConnell, Majority Leader of the United States Senate, Letter to the Hon. Charles Schumer, Minority of the United States Senate - Capito, Manchin Lead Bipartisan Effort to Extend Funding for Community Health Centers
03/27/2019 Letter to the Hon. Patrick Shanahan - Senator Murray Demands Answers from Defense Department Following Transfer of $1 Billion in Military Personnel Funding to Pay for President Trump's Border Wall
07/16/2018 Letter to Ian C. Read, Chief Executive Officer of Pfizer Inc. - Make Drug Price Reductions Permanent
04/18/2018 Letter to the Hon. Alex Azar, Secretary of Health and Human Services - Stabenow, Peters Call on Administration to Take Immediate Action to Reduce Price of Naloxone, a Life-Saving Opioid Overdose Reversal Drug
03/08/2018 Letter to the Hon Thad Cochran, Chairman of the Senate Appropriations Committee, the Hon Patrick Leahy, Vice Chairman of the Senate Appropriations Committee, the Hon Roy Blunt, Chairman of the Subcommittee on Labor, HHS, Education and Related Agencies and the Senate Appropriations Committee, and the Hon Patty Murray, Ranking Member of the Subcommittee on Labor, HHS, Education and Related Agencies and the Senate Appropriations Committee - Senator Cantwell, Colleagues Call for Increased Investment in Student Health, Safety
03/07/2018 Letter to the Hon Thad Cochran, Chairman of the Committee of Appropriations, and the Hon Patrick Leahy, Ranking Member of the Committee on Appropriations - Senator Cantwell Pushes for Additional Funding to Combat Opioid Crisis, Support Treatment Efforts in Indian Country
03/05/2018 Letter to the Hon. Thad Cochran, Chairman of the Senate Appropriations Committee, the Hon. Patrick Leahy, Vice Chairman of the Senate Appropriations Committee, the Hon. Roy Blunt, Chairman of the Subcommittee on Labor, Health and Human Services, and Education, and the Hon. Patty Murray, Ranking Member of the Subcommittee on Labor, Health and Human Services, and Education - Advocate for Resources to Combat Opioid Crisis in Foster Care System
03/02/2018 Letter to Aetna, AHIP, Anthem, BCBS, CareSource, Centene, Cigna, Humana, Kaiser, Molina, and UnitedHealth - Step Up Response to Opioid Epidemic
03/01/2018 Letter to Bruce D. Broussard, Chief Executive Officer & President of Humana - Feinstein, Brown, Markey Ask Health Insurers to Step Up Response to Opioid Epidemic
Page 1 of 3
arrow_upward